17β-Hydroxysteroid dehydrogenase Type 1 and Type 2: Association between mRNA expression and activity in cell lines
Authors:
- Joanna M. DayJDJoanna M. Day
- Helena J. TutillHTHelena J. Tutill
- Simon P. NewmanSNSimon P. Newman
- Atul PurohitAPAtul Purohit
- Harshani R. LawrenceHLHarshani R. Lawrence
- Nigel VickerNVNigel Vicker
- Barry V.L. PotterBPBarry V.L. Potter
- Michael J. ReedMRMichael J. Reed
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 248 (1-2) , 246-249
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The regulation and inhibition of 17β-hydroxysteroid dehydrogenase in breast cancerMolecular and Cellular Endocrinology, 2006
- Novel and Potent 17β-Hydroxysteroid Dehydrogenase Type 1 InhibitorsJournal of Medicinal Chemistry, 2005
- 17β-Hydroxysteroid Dehydrogenase Type 1 Is an Independent Prognostic Marker in Breast CancerCancer Research, 2004
- Human 17β-hydroxysteroid dehydrogenases types 1, 2, and 3 catalyze bi-directional equilibrium reactions, rather than unidirectional metabolism, in HEK-293 cellsArchives of Biochemistry and Biophysics, 2004
- The role of 17 beta-hydroxysteroid dehydrogenasesMolecular and Cellular Endocrinology, 2004
- Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genesGenome Biology, 2002
- Human 17 β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expressionBiochemical Journal, 1996
- INSULIN-LIKE GROWTH FACTOR TYPE I AND INSULIN-LIKE GROWTH FACTOR TYPE II STIMULATE OESTRADIOL-17β HYDROXYSTEROID DEHYDROGENASE (REDUCTIVE) ACTIVITY IN BREAST CANCER CELLSJournal of Endocrinology, 1991